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Abstract 
Background: Orthopedic implant-related sarcoma is an exceedingly rare, but a known complication of total hip 
arthroplasty (THA).
Case presentation: The authors describe clinical and radiologic features, histologic appearance, and treatment of 
osteogenic osteosarcoma located in the proximal femoral diaphysis associated with an unstable femoral prosthesis 
following THA in a 65-year-old male patient. The patient with HLA-B27 positive ankylosing spondylitis underwent 
arthroplasty 15 years ago.
Conclusions: The neoplastic process may be considered as an extraordinary complication of THA and might just 
be coincidental or the result of some derangement of the healing process in host tissue with no definitely proven 
hypothesis that the implants or their by-products are carcinogenic. The soluble chemical substances from the 
implanted prosthetic material are, at least in animals, suspected to play a vital role in the pathogenesis of the neoplas-
tic transformation of the bone tissue. The presented case shall alert orthopedic surgeons to clinical, radiologic, and 
macroscopic similarities between a malignant tumor and benign lesions caused by wear debris at THA sites. At the 
examination of plane X-rays of patients with THA loosening, the differential diagnosis should always include osteo-
genic sarcoma, as well. To our knowledge, there have been only nine cases of THA-related osteogenic osteosarcomas 
described in the English-language literature.
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Background
The exact etiopathogenesis of the osteosarcoma is poorly 
understood. Most of them arise de novo, but some of 
them appear in the setting of some premalignant condi-
tions. Among them are congenital syndromes associated 
with osteosarcoma (familial retinoblastoma, Bloom syn-
drome, familial Paget disease, Li-Fraumeni syndrome, 
Werner syndrome, Rothmund–Thomson syndrome), 
Paget disease, giant cell tumor, osteoblastoma, and 
fibrous dysplasia [1].
Radiation exposure, chronic osteomyelitis, and metal 
endoprosthesis implantation are also well-known predis-
posing factors for osteosarcoma [2–6].
Sarcoma at the site of the metal foreign bodies was 
reported in the Western literature as early as 1888 [7]. 
However, the malignancies in the vicinity of the total hip 
arthroplasty (THA) are extremely rare. In the 30-year-
long period—from 1974 to 2003, 46 different malignant 
tumors at the site of the THA were reported in the Eng-
lish-language literature and among them only 9 were 
osteosarcomas [3, 5, 6, 8–20].
Herewith, we describe a case of a THA-related osteo-
genic osteosarcoma.
Case report
A 65-year-old Caucasian male was admitted to our hos-
pital with a history of slowly developing pain in his left 
thigh in April 2015. The patient has undergone a THA 
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positive ankylosing spondylitis (AS) fifteen and twelve 
years prior to this presentation. Clinical examination 
disclosed a typical stiff spine and a pain-free right hip 
with excellent range of motion (ROM). Left hip was 
painful and has reduced ROM. There was no sign of pal-
pable soft-tissue mass or enlarged inguinal and pelvic 
nodes. Pelvic and hip X-rays showed a radiolucent osteo-
lytic zone around the tip of the uncemented left femo-
ral stem consistent with aseptic loosening of prosthesis 
(Fig. 1).
Chest X-ray and blood tests were normal. According 
to these findings, the patient was scheduled for regular 
revision and replacement of the left THA. The prosthesis 
used in primary THA was an anatomically shaped unce-
mented model, made of Titanium Aluminum Vanadium 
(Ti6Al4V) Alloy (Ti, Al-6  %, V-4  %) proximally coated 
with hydroxyapatite.
During the revision procedure, the femoral stem was 
found loose and the acetabular component was well fixed. 
However, there were signs of wear and tear at the modu-
lar head and acetabular inlay. It was decided to replace all 
components of the primary arthroplasty. Routine tissue 
samples were collected for microbiological analysis and 
histologic examination from several different locations. 
The femoral bone was thinned and the soft tissue around 
femoral shaft of the loosened prosthesis was not suspi-
cious for tumor. Frozen section of the tissue around the 
loosened femoral stem was not performed.
Several small tissue samples from different locations 
(labeled as pseudocapsule, bone, tissue from the femoral 
canal) were submitted for histopathologic examination. 
In some of the samples, rare thin normal bony trabecu-
lae were found; in most samples the submitted tissue was 
hypercellular, fibroblastic, and arranged in poorly formed 
fascicles (Fig. 2).
More collagenized tissue revealed a less dense cellular-
ity. The cells were focally pleomorphic and haphazardly 
arranged. Necroses were not found. Mitotic figures were 
present in hypercellular spindle- and pleomorphic-cell 
areas (Fig. 3).
In less than 10 % of examined tissue, a lace-like eosino-
philic osteoid without signs of mineralization or ossifica-
tion was seen among pleomorphic cells (Fig. 4).
All tumor cells in fibroblastic areas were immunohis-
tochemically diffusely positive to NSE, CD99, smooth 
muscle actin, calponin, focally for CKAE1/AE3, and cal-
retinin. Only few isolated cells were positive for EMA, 
β-catenin, E-cadherin, S-100 protein, caldesmon, CD56 
NCAM, Bcl-2, and CD117. All cells were negative for 
estrogen and progesterone receptors, CD34, and desmin. 
Predominantly in osteoblastic foci, the cells were mostly 
SATB2 positive (Fig. 5).
The so-called arthroplasty effect was not present in or 
near the tumor. According to morphology and immuno-
histochemistry, the lesion was recognized as a second-
ary, orthopedic implant-related conventional osteogenic 
osteosarcoma, a fibroblastic type with rare osteoblastic 
foci, without lymphovascular invasion. All microbiology 
samples were sterile.
Unaware of the histological diagnosis during the opera-
tion, the orthopedic surgeon did not perform a radi-
cal femoral resection. Instead, an uncemented revision 
total hip prosthesis with long femoral stem was inserted 
(Fig. 6).
The postoperative course was uneventful and the 
patient was discharged on day 6 postoperatively. 
Fig. 1 a Anteroposterior radiograph of the pelvis with both THA inserted. Note signs of femoral stem loosening on the left side. b Left hip lateral 
radiograph with osteolytic zone around the distal femoral stem
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Regarding the histopathological diagnosis, the patient 
was readmitted for computed tomography of the chest 
revealing two possible lung metastases and suspicious 
lesions in the 4th, 9th, and 10th thoracic vertebrae. Since 
the tumor has not been radically excised and a possible 
metastatic dissemination was suspected, the patient was 
treated with adjuvant chemotherapy (cisplatin, doxoru-
bicin, and Lonquest to reduce neutropenia); 6  months 
after the diagnosis was established, he is well and shows 
no signs of local recurrence or systemic progression.
Discussion
Artificial orthopedic hardware made of metals, ceramics, 
or plastic materials has been used for decades to repair 
the function of poorly functioning and painful joints. 
Only in 1996, over 140,000 THA were performed in the 
USA [21]. All those biomaterials are generally believed 
to be nontoxic. However, some of the constituents have 
been shown to promote neoplasia in the animal studies 
[22–27]. Sinibaldi reported an association of malignan-
cies and the orthopedic implants in pets and Murphy 
described a case of osteosarcoma following THA in a dog 
[28, 29]. Foreign bodies of metallic cobalt, metallic nickel, 
and alloy powder containing 66–67 % of nickel, 13–16 % 
of chromium, and 7 % of iron have been classified as pos-
sible carcinogens to humans. Contrary, implanted foreign 
bodies made of metallic chromium or titanium and of 
cobalt- and/or titanium-based alloys, stainless steel, and 
Fig. 2 Malignant spindle cells arrangement in poorly formed fascicu-
lar pattern in fibroblastic part of the tumor (HE, 100×)
Fig. 3 Highly pleomorphic cells; some multinucleated with minimal 
deposition of intercellular osteoid in the top of the picture. Mitotic 
figure is present—see arrow (HE, 200×)
Fig. 4 Non-mineralized eosinophilic osteoid between tumor cells in 
osteoblastic focus (HE, 200×)
Fig. 5 Most of the cells in osteoblastic foci were SATB2 immunoreac-
tive (SATB2, 100×)
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organic polymeric materials are not believed to be car-
cinogenic to humans [30]. High concentration of pros-
thetic metal in synovial fluid and capsular tissue around 
the loosened prostheses are believed to be the result of 
continuous liberation of the metal and plastic particles 
from the constant rubbing of the artificial joint’s surfaces 
[31, 32].
Our review of the literature identified nine previously 
described cases; ours would be the tenth case of osteosar-
coma associated with THA. Data about prosthesis type, 
material the prosthesis was made of, its mode of fixation, 
preoperative diagnosis, latent period from arthroplasty, 
age and sex of the patient, involved tissue, treatment and 
outcome are summarized in Table 1 (some data are miss-
ing). In four patients, the prosthesis was anchored with 
cement and in four patients (including ours) the prosthe-
sis was uncemented. All patients were exposed to known 
common metal alloys used for THA (3 to CoCr, 3 to Ti 
alloy, 2 to stainless steel). The mean patient’s age at the 
time of diagnosis was 65.8 years and ranged from 54 to 
75 years. 6 patients were female, and four were male. Six 
patients underwent THA for osteoarthritis (OA), one had 
a hip dysplasia with secondary OA, one had radiation-
induced necrosis of the femoral head, and one had AS. In 
all ten patients, the bone and the surrounding soft tissue 
was involved by the sarcoma. The time interval between 
THA and diagnosis of the tumor ranged from 6 months 
to 15 years (mean 6.4 years for all ten patients).
The leading symptoms of the affected hips were 
increasing pain, stiffness, swelling, and reduced ROM. 
Lung metastases were present in seven patients and renal 
metastases in one patient. The prognosis of the patients 
with THA-related osteosarcomas was poor: the mean 
survival time from the diagnosis to death was 6 months, 
ranged from 9 days to 1 year (for six patients).
An unusual aspect of the presented case is that the 
patient had his bilateral THA performed 12 and 15 years 
previously—much longer than the average interval 
between THA and diagnosis of the tumor reported in 
reviewed cases. Both implanted THA were of the same 
type and mode of fixation indicating the same influence 
of the implanted material or their by-products on the 
bone and soft tissue of both hips. And yet, osteosarcoma 
has emerged on one side only, which casts some doubt on 
the role of the former factors in its pathogenesis.
Conclusions
We present a case of one-side THA-related osteogenic 
osteosarcoma in a 65-year-old man with bilateral THA 
and with the longest latent period from the performed 
THA to established diagnosis reported so far.
Given the large number of total hip arthroplasties that 
are routinely performed all over the world, the develop-
ment of a malignant lesion appears to be an extraordinary 
complication and may be just a coincidence or the result 
of some derangement of the healing process in host tissue 
Fig. 6 a Anteroposterior radiograph of the pelvis taken after revision of THA on the left side. b Anteroposterior radiograph of the femur showing tip 
of long revision femoral stem
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with no definitely proven hypothesis that the implants or 
their by-products are carcinogenic. The very low number 
of confirmed cases of implant-related tumors in humans 
makes such a hypothesis very uncertain.
The importance of our presented case is to alert ortho-
pedic surgeons to the clinical, radiologic, and mac-
roscopic similarities between a malignant tumor and 
benign lesions caused by wear debris at THA sites. At the 
examination of plane X-rays of patients with THA loos-
ening, the differential diagnosis should always include 
osteogenic sarcoma, as well.
Consent
“Written informed consent was obtained from the patient 
for publication of this Case report and any accompanying 
images.
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